Judd R C, Rudbach J A
Diagn Immunol. 1985;3(1):1-6.
Glycogen-induced guinea pig polymorphonuclear leukocytes (PMNs) were employed in experiments designed to establish the optimal conditions for casein-stimulated chemotaxis. Subsequently, it was shown that guinea pig PMNs, in a serum-free medium, were susceptible to inhibition of migration by three distinct types of cell-directed inhibitors of chemotaxis found in normal or diseased human sera. Comparison of inhibition of migration of both guinea pig and human peripheral PMNs showed that guinea pig and human PMNs were equally susceptible to inhibition by sera from trauma victims; this inhibitor had a molecular weight of about 10,000 d. Human PMNs were slightly more susceptible than were guinea pig PMNs to inhibition of migration by a approximately 110,000-d inhibitor found in normal human sera. On the other hand, guinea pig PMNs were somewhat more susceptible to inhibition of migration by a approximately 400,000-d inhibitor of chemotaxis that was analogous to the inhibitor found in anergic serum. This information shows that guinea pig PMNs, in a serum-free medium, may be substituted for human cells in quantitative assays for these human serum factors.
糖原诱导的豚鼠多形核白细胞(PMNs)被用于实验,这些实验旨在确定酪蛋白刺激趋化作用的最佳条件。随后发现,在无血清培养基中,豚鼠PMNs易受正常或患病人类血清中发现的三种不同类型的细胞定向趋化抑制剂的迁移抑制作用。对豚鼠和人类外周血PMNs迁移抑制作用的比较表明,豚鼠和人类PMNs对创伤受害者血清的抑制作用同样敏感;这种抑制剂的分子量约为10,000道尔顿。与豚鼠PMNs相比,人类PMNs对正常人血清中发现的约110,000道尔顿的抑制剂的迁移抑制作用稍更敏感。另一方面,豚鼠PMNs对一种约400,000道尔顿的趋化抑制剂的迁移抑制作用稍更敏感,该抑制剂类似于无反应血清中发现的抑制剂。这一信息表明,在无血清培养基中,豚鼠PMNs可在这些人类血清因子的定量测定中替代人类细胞。